| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2021 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DHI Group Inc | 4 | Q3 2022 | 7.9% |
| Tetra Technologies Inc | 4 | Q3 2022 | 6.5% |
| Harrow Health Inc | 4 | Q3 2022 | 8.4% |
| TTEC Holdings Inc | 4 | Q3 2022 | 5.9% |
| Clarus Corp | 4 | Q3 2022 | 5.9% |
| Apyx Medical Corp | 4 | Q3 2022 | 6.5% |
| InfuSystem Holdings Inc | 4 | Q3 2022 | 5.1% |
| PAR Technology Corp | 4 | Q3 2022 | 4.9% |
| Cantaloupe Inc | 4 | Q3 2022 | 5.2% |
| Marcus Corp | 4 | Q3 2022 | 4.4% |
View Invenire Partners, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2023-03-31 |
| SC 13G | 2023-01-23 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| D/A | 2019-03-12 |
| D | 2018-01-02 |
View Invenire Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.